Endogenous Catecholamines in Immune Cells: Discovery, Functions And Clinical Potential as Therapeutic Targets
Experimental Study Shows that Learned Immunosuppressive Placebo Responses Attenuate Disease Progression in a Rat Model of Arthritis
FDA Authorizes an Emergency Use for Bamlanivimab – an Investigational Monoclonal Antibody – for the Treatment of Mild to Moderate COVID-19
NIH begins the first large randomized controlled trial of the combination of interferon beta-1a and remdesivir for treating COVID-19
Donna Jackson Nakazawa and Her New Book, THE ANGEL AND THE ASSASSIN: The Tiny Brain Cell that Changed the Course of Medicine
The Emerging Role of Neuro-Immune Synapses and the Immunological Homunculus in the Context of the Systematic Lymphoid Organs InnervationJuly 18, 2019
Hyperactive Type I Interferon System in the Choroid Plexus Linked To Aging and Cognitive DysfunctionSeptember 4, 2014
Endogenous Catecholamines in Immune Cells: Discovery, Functions And Clinical Potential as Therapeutic TargetsOctober 5, 2013
